SSR Health
SSR Health LLC is a privately held US data and analytics company founded in 2009 that provides proprietary prescription brand drug pricing data and IRA selection probability forecasts to pharmaceutical manufacturers, policymakers, academics, and trade associations.
- Company typePrivate
- Founded2009
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What SSR Health does
SSR Health LLC is a US-based, privately held data and analytics company founded in 2009 by Dr. Richard Evans that specializes in prescription brand drug pricing intelligence. Its core offering is a proprietary net price database covering approximately 1,000 US brand name prescription drugs across more than 100 companies on a quarterly basis since 2007, delivered through a customizable Tableau Online platform. The company also operates the IRA Selection Tool, a probabilistic prediction framework that models drug-level selection odds for the Inflation Reduction Act's Drug Price Negotiation Program across at least three IPAY forecast horizons, grounded in 100% Part D and Part B CMS spending files.
The firm's revenue model is built on quote-based annual enterprise subscriptions supplemented by individual quarterly report purchases, with all sales routed through a direct engagement model managed by a four-person team that includes the founder/GM, a healthcare economist heading new product development, an analyst responsible for pricing and R&D modeling, and a sales head. Customers span four primary segments: pharmaceutical brand manufacturers, academic and research institutions, federal and state policymakers, and pharmaceutical trade associations. Marketing relies primarily on earned media and academic citations rather than paid acquisition, with SSR Health data and commentary regularly appearing in STAT News, Bloomberg, the Wall Street Journal, JAMA, and Health Affairs.
SSR Health operates as an unfunded, founder-owned LLC with no disclosed institutional investors, no parent company, and no acquisition history. Its competitive position rests on the longitudinal proprietary dataset, the exclusive integration of full CMS Part D and Part B spending files, the IRA-specific probabilistic methodology, and the domain credibility of its principals, who combine buy-side equity research pedigree with applied health economics consulting experience. The company currently serves only the US market, with no international footprint or app distribution channels.
SSR Health firmographics
Firmographics- Name
- SSR Health
- Legal name
- SSR Health LLC
- Website
- https://ssrhealth.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SSR Health LLC is a privately held US data and analytics company founded in 2009 that provides proprietary prescription brand drug pricing data and IRA selection probability forecasts to pharmaceutical manufacturers, policymakers, academics, and trade associations.
- Ownership category
- akta.pro rank
SSR Health industry classification
Industry- Product category
- Pharmaceutical Pricing Analytics
- NAICS
- Marketing Research and Public Opinion Polling (541910), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Pricing & Contracting Strategy (HLAIAKAA)
- akta.pro secondary industries
- Medicare Quality, Risk Adjustment & Stars Analytics/Services (FSAIAGAJ), Medication Analytics, Outcomes & Cost Optimization (HLACAKAL)
Keywords
SSR Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel
Revenue model
- Data Subscription Access: Subscription-based access to proprietary net pricing database through web-based interface, providing standardized analyses and customized reporting capabilities.
- Individual Report Purchases: Individual report purchases for specific quarterly reports and specialized analysis products. Reports are delivered in PDF format within 24 hours of request.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise subscription with full database access and customized analyses |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
SSR Health product offering
Product offeringCore offering
SSR Health provides US prescription brand drug pricing data and analytics through two primary products: the US Prescription Brand Net Pricing Data Tool, which delivers quarterly gross and estimated net pricing data since 2007 for approximately 1,000 products across 100+ companies, and the IRA Selection Tool, which uses a proprietary probabilistic prediction framework built on 100% CMS Part D and Part B spending files to forecast drug-level odds of selection under the Medicare Drug Price Negotiation Program. Both products are delivered through a Tableau Online web-based interface, complemented by quarterly pricing trend reports and regulatory/political impact analyses.
Product overview
SSR Health offers a unified platform comprising two primary products: the US Prescription Brand Net Pricing Data Tool and the IRA Selection Tool. The Net Pricing Data Tool delivers quarterly gross and net pricing analytics for approximately 1,000 US brand name prescription drugs across 100+ companies via a Tableau Online interface, while the IRA Selection Tool provides probabilistic predictions for Medicare drug price negotiation selection. Supporting modules include quarterly pricing trend reports and regulatory impact analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- IRA Selection Tool Web-based tool that provides drug-level probabilities of selection for the IRA Drug Price Negotiation Program, including historical changes in those probabilities and quarterly updates to incorporate new policies, guidance, and drug-specific events and sales dynamics. Driven by a proprietary probabilistic prediction framework informed by 100% CMS Part D and Part B spending files, using a bootstrapped model based on a census of Medicare lifecycles. Designed for pharmaceutical brand manufacturers, policymakers, and trade associations assessing direct and indirect IRA impacts.
- US Prescription Brand Net Pricing Data Tool Web-based platform that incorporates quarterly gross and estimated net pricing data and trends since 2007 for every quarter going forward, covering approximately 1,000 active US brand name prescription drugs across more than 100 companies. Includes WAC-to-net concessions, Medicaid versus non-Medicaid concessions, product roll-up to industry, therapeutic area, and company levels, and both WAC and net prices by year or course of therapy. Delivered via a Tableau Online interface with standardized and customized analyses for manufacturers, trade associations, policymakers, and academic researchers.
- Quarterly Pricing Trend Reports Individual quarterly reports identifying and assessing positive and negative drivers — by company, therapeutic area, and product — of aggregate net pricing trends, as well as factors influencing pharma market dynamics such as co-pay accumulators and formulary exclusions. Delivered in PDF format within 24 hours of purchase.
- US Political and Regulatory Analysis Standalone analyses of new and proposed legislation and directives — including the Prescription Drug Pricing Reduction Act (PDPRA), International Pricing Index, Anti-Kickback Statute (AKS) safe harbor rule, and the Inflation Reduction Act — and their industry impact on products, segments, and companies. Available as individual report purchases.
Quantifiable outcome
- Coverage of approximately 1,000 brand name prescription drugs across more than 100 companies
- +1 more outcomes
Companies that use SSR Health
Customer profileSegments4 records
Ideal customer profiles3 records
SSR Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
SSR Health partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
SSR Health competitors and assessment
Company assessmentBroad incumbents
- Optum (UnitedHealth Group): Optum's health analytics and research divisions provide large-scale claims, prescription, and pricing data to pharma and policymakers. While far broader in scope, it overlaps with SSR Health's Medicare Part D/B spending analysis and policy impact use cases.
- Wolters Kluwer (Pharma & Regulatory Solutions / Sentinel): Wolters Kluwer offers pharma regulatory and drug-pricing reference data products used by manufacturers and policymakers, comparable to SSR Health's regulatory analysis and pricing data offerings, but as part of a much broader professional information portfolio.
- IQVIA: IQVIA is the largest global healthcare data and analytics company, offering prescription and commercial datasets (e.g., Xponent, DDD) that overlap with SSR Health's US brand pricing analytics, though IQVIA serves a much broader portfolio of pharma customers.
Emerging players
- Drug Channels Institute: Drug Channels Institute, founded by Adam Fein, produces influential research and analysis on pharmaceutical pricing, distribution, and rebate dynamics. Its content and insights overlap with SSR Health's thought leadership on gross-to-net pricing and market dynamics.
- Numerof & Associates: Numerof & Associates is a healthcare strategy consulting firm that helps pharma manufacturers with pricing, market access, and policy impact analysis. It serves a comparable buyer base and addresses overlapping problems with SSR Health's regulatory impact analytics.
Direct peers
- Norstella (EvaluatePharma): Norstella owns EvaluatePharma and other pharma market intelligence assets that forecast drug sales, pricing, and market access dynamics. Both SSR Health and Norstella serve pharma manufacturers with forecasting and pricing intelligence, though SSR Health is more narrowly focused on net pricing and IRA selection probabilities.
- Simon-Kucher & Partners: Simon-Kucher is a global consulting firm specializing in pricing, monetization, and market access strategy, with deep pharma pricing expertise. It competes with SSR Health's value proposition of helping manufacturers optimize gross-to-net pricing and contracting.
- ZS Associates: ZS Associates is a consulting firm with a dedicated pharma pricing, market access, and analytics practice serving brand manufacturers. It overlaps with SSR Health's customer base and use cases around gross-to-net pricing strategy and contracting analytics.
- Definitive Healthcare: Definitive Healthcare provides commercial intelligence for the healthcare and life sciences industry, including prescription and provider data used for market access decisions. It serves a similar set of manufacturer and consulting buyers as SSR Health.
- Cencora (formerly AmerisourceBergen / Xcenda): Cencora's consulting arm (formerly Xcenda) provides pharma pricing, market access, and reimbursement analytics to manufacturers, overlapping directly with SSR Health's gross-to-net pricing and policy impact offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SSR Health social profiles
Digital presenceSSR Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
SSR Health leadership team
Management profileNumber of profiles
Profiles4 records
SSR Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SSR Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SSR Health
What does SSR Health do?
SSR Health provides US prescription brand drug pricing data and analytics through two primary products: the US Prescription Brand Net Pricing Data Tool, which delivers quarterly gross and estimated net pricing data since 2007 for approximately 1,000 products across 100+ companies, and the IRA Selection Tool, which uses a proprietary probabilistic prediction framework built on 100% CMS Part D and Part B spending files to forecast drug-level odds of selection under the Medicare Drug Price Negotiation Program. Both products are delivered through a Tableau Online web-based interface, complemented by quarterly pricing trend reports and regulatory/political impact analyses.
Is SSR Health a public or private company?
SSR Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SSR Health founded?
SSR Health was founded in 2009. It employs 1 to 10 people.
How does SSR Health make money?
Two revenue lines are on record. Data Subscription Access are the primary driver. The others are individual Report Purchases.
Who are SSR Health's main competitors?
Broad incumbents on record are Optum (UnitedHealth Group), Wolters Kluwer (Pharma & Regulatory Solutions / Sentinel) and IQVIA. Emerging players are Drug Channels Institute and Numerof & Associates. Direct peers are Norstella (EvaluatePharma), Simon-Kucher & Partners, ZS Associates, Definitive Healthcare and Cencora (formerly AmerisourceBergen / Xcenda).
Does SSR Health have an API?
No public API is recorded for SSR Health.
What industry is SSR Health in?
SSR Health's product category is Pharmaceutical Pricing Analytics. Its primary akta.pro industry code is HLAIAKAA, Pricing & Contracting Strategy, with a secondary code of FSAIAGAJ, Medicare Quality, Risk Adjustment & Stars Analytics/Services. Its NAICS code is 541910 and its SIC code is 7372.